Document Detail


The atypical antipsychotic sertindole: a case series.
MedLine Citation:
PMID:  9378698     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Psychotic disorders are often difficult to treat with traditional neuroleptics. Sertindole is a new atypical neuroleptic with a broader CNS receptor profile. METHOD: Ten patients diagnosed with either schizophrenia or schizoaffective disorder were treated with sertindole for 18 months and observed for changes in Clinical Global Impression scale scores. RESULTS: Nine patients experienced a reduction of symptoms after 12 months of treatment. Eight patients completed 18 months of treatment, all exhibiting overall improvement. Despite side effects of tiredness, weight gain, headache, nausea, and decreased ejaculatory volume, sertindole was generally well tolerated. CONCLUSION: Sertindole appears to be a useful treatment in psychotic disorders. It may present an advantage over traditional neuroleptics in the form of fewer extrapyramidal symptoms and improvement of negative symptoms.
Authors:
A M Lee; J L Knoll; T Suppes
Related Documents :
24462578 - Diagnosis and molecular basis of mitochondrial respiratory chain disorders: exome seque...
23745228 - Lichen planus pigmentosus.
23028568 - Connection between genetic and clinical data in bipolar disorder.
23695058 - Burden of migraine: international perspectives.
19006198 - Evidence-based guidelines for interpretation of the panic disorder severity scale.
20976638 - Psychotherapy treatment program in a group of adults with high-functioning autism spect...
Publication Detail:
Type:  Case Reports; Clinical Trial; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Journal of clinical psychiatry     Volume:  58     ISSN:  0160-6689     ISO Abbreviation:  J Clin Psychiatry     Publication Date:  1997 Sep 
Date Detail:
Created Date:  1997-11-07     Completed Date:  1997-11-07     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7801243     Medline TA:  J Clin Psychiatry     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  410-6; quiz 417-8     Citation Subset:  IM    
Affiliation:
Mental Health Connections Research, Dallas, Texas, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Antipsychotic Agents / adverse effects,  pharmacology,  therapeutic use*
Delusions / drug therapy*,  psychology
Drug Administration Schedule
Female
Headache / chemically induced
Humans
Imidazoles / adverse effects,  pharmacology,  therapeutic use*
Indoles / adverse effects,  pharmacology,  therapeutic use*
Male
Middle Aged
Nausea / chemically induced
Psychiatric Status Rating Scales
Psychotic Disorders / drug therapy*,  psychology
Receptors, Adrenergic, alpha / drug effects
Receptors, Dopamine D2 / drug effects
Receptors, Serotonin / drug effects
Schizophrenia / drug therapy*
Schizophrenic Psychology
Treatment Outcome
Weight Gain
Chemical
Reg. No./Substance:
0/Antipsychotic Agents; 0/Imidazoles; 0/Indoles; 0/Receptors, Adrenergic, alpha; 0/Receptors, Dopamine D2; 0/Receptors, Serotonin; 106516-24-9/sertindole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome.
Next Document:  GPI-anchor synthesis in mammalian cells: genes, their products, and a deficiency.